凝結芽孢桿菌的全球市場 (2023-2030年)

凝結芽孢桿菌市場規模預計將從 2019 年的 6.345 億美元增長到 2028 年的 9.71 億美元，預測期內複合年增長率為 5.93%。Masu。

從應用來看，烘焙業預計將從 2019 年的 1.926 億美元成長到 2028 年的 2.859 億美元，複合年增長率為 5.58%。此外，動物飼料產業在預測期內複合年增長率最高，為 6.75%，預計到 2028 年將達到 4,690 萬美元。2019年，烘焙和糖果業合計佔有率約為51.5%，僅烘焙業的佔有率約為30.4%。

消費者對具有改善消化健康和增強免疫力等健康益處的益生菌產品的需求不斷增加，也推動了全球凝結芽孢桿菌市場的成長。此外，凝結芽孢桿菌在食品和飲料、藥品和飼料等各行業的使用不斷增加，為進入者提供了利潤豐厚的機會。

本報告提供全球凝結芽孢桿菌的市場調查，彙整市場概要，市場成長的各種影響因素分析，市場規模的轉變·預測，各種區分·各地區的明細，競爭情形，主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 凝結芽孢桿菌市場:各用途

• 麵包店
• 糖果零食類
• 乳製品
• 飲料
• 機能性食品
• 動物飼料

第4章 凝結芽孢桿菌市場:各地區

• 北美
• 歐洲
• 亞洲
• 其他地區

第5章 凝結芽孢桿菌市場:各企業

• DuPont
• Ganeden
• Sabinsa Corporation
• Kerry Group
• ADM (Archer Daniels Midland Company)
• UAS Labs
• NutraScience Labs
• Deerland Enzymes
• Syngenta
• Merck & Co.

第8章 附錄

REPORT OBJECTIVES

The report "Bacillus Coagulans : Global Market Intelligence ( 2023-2030 ) " provides market intelligence on the different market segments, based on Application, Region, Company etc. Market size and forecast (2020-2030) has been provided in the report. The primary objectives of this report are to provide 1) comprehensive global market intelligence through detailed segmentation, 2) market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends, 3) detailed analysis of current dynamics and trends, key market players, and strategies in the market, 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants, 5) provide emerging opportunities in the market and the future impact of major drivers and restraints of the market and, 6) support decision makers in making cost-effective business decisions.

RESEARCH METHODOLOGY

In our market size and forecast determination efforts, an extensive secondary research was initially completed to gain a good perspective of the market in each region. Extensive primary research was also carried out by interviewing the key executives from the industry. These interviews helped us to fill-in the data gaps after secondary research. Several secondary sources such as encyclopedia, directories, and databases have been used to identify and collect information useful for this extensive techno-commercial study. The respondents - selected experts from manufacturers and selected suppliers - have been interviewed to obtain and verify critical information as well as to assess the future prospects. The usage of obtained information is based on the perceived reliability by the research team. In many cases, a combination of several sources was used. Sprout Intelligence provides an in-depth analysis of the market segmentation, which is a critical element of the market intelligence reports at Sprout Intelligence.

KEY AUDIENCE

Executives in marketing, strategic planning and new product development will find such discussions in our reports pertinent and useful. Management consultants, investment bankers, manufacturers, distributors, suppliers, and regulatory authorities are amongst our regular clientele served.

DATA SOURCES

The general data sources used in this report are company websites, trade association publications, regulatory authorities, journals, magazines, news websites, press releases, media publications, interaction with industry experts, company executives, research papers, articles, patents, scientific literature, among many others.

KEY FINDINGS FROM THE REPORT

The Bacillus Coagulans market was valued at $634.5 Million in 2019, and is projected to reach $971.0 Million by 2028 growing at a CAGR of 5.93% from 2020 to 2028.

Bakery segment is expected to be the highest contributor to this market, with $192.6 Million in 2019, and is anticipated to reach $285.9 Million by 2028, registering a CAGR of 5.58%.

Animal Feed segment is anticipated to reach $46.9 Million by 2028 with the highest CAGR of 6.75%.

Bakery and Confectionery segments collectively expected to account for about 51.5% share of the Bacillus Coagulans market in 2019, with the former constituting around 30.4% share.

Animal Feed and Confectionery segments are expected to witness significant growth rates at a CAGR of 6.75% and 6.52% respectively, during the forecast period.

Presently, share of these two segments is estimated to be around 25.7% in the overall Bacillus Coagulans market in 2019, and is anticipated to reach 27.1% by 2028.

The global Bacillus Coagulans market is being primarily driven by the increasing consumer demand for probiotic products with health benefits such as digestive health improvement and immunity enhancement.

This rising awareness of the positive effects of Bacillus Coagulans on gut health is propelling market growth.

Additionally, the expanding application of Bacillus Coagulans in various industries, including food and beverages, pharmaceuticals, and animal feed, presents lucrative opportunities for market players to diversify their product offerings and expand their customer base.

This trend is further bolstered by the growing focus on preventive healthcare and the proactive efforts of manufacturers to develop innovative formulations that incorporate Bacillus Coagulans for a broader range of health-conscious consumers..

Table of Contents

1. Report Introduction

• 1.1. Report Description
  • 1.1.1. Research Methodology
  • 1.1.2. Report Objectives
  • 1.1.3. Data Sources
• 1.2. Acronyms / Abbreviations
• 1.3. Assumptions
• 1.4. Limitations

2. Executive Summary

3. Bacillus Coagulans Market, by Application

• 3.1. Bakery
• 3.2. Confectionery
• 3.3. Dairy Products
• 3.4. Beverages
• 3.5. Functional Food
• 3.6. Animal Feed

4. Bacillus Coagulans Market, by Region

• 4.1. North America
  • 4.1.1. US
  • 4.1.2. Canada
• 4.2. Europe
  • 4.2.3. Germany
  • 4.2.4. U.K.
  • 4.2.5. France
  • 4.2.6. Italy
  • 4.2.7. Spain
  • 4.2.8. Rest of Europe
• 4.3. Asia
  • 4.3.9. China
  • 4.3.10. Japan
  • 4.3.11. S. Korea
  • 4.3.12. India
  • 4.3.13. Thailand
  • 4.3.14. Rest of Asia
• 4.4. ROW
  • 4.4.15. Brazil
  • 4.4.16. Mexico
  • 4.4.17. South Africa
  • 4.4.18. Rest of the World

5. Bacillus Coagulans Market, by Company

• 5.1. DuPont
• 5.2. Ganeden
• 5.3. Sabinsa Corporation
• 5.4. Kerry Group
• 5.5. ADM (Archer Daniels Midland Company)
• 5.6. UAS Labs
• 5.7. NutraScience Labs
• 5.8. Deerland Enzymes
• 5.9. Syngenta
• 5.10. Merck & Co.

8. Appendix

• 8.1. Disclaimer
• 8.2. About Sprout Intelligence